Nama's AI scorecard currently rates Medtronic Buy (6.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is MDT's P/E ratio?

Medtronic trades at a trailing price-to-earnings ratio of 17.8.

When does MDT report earnings?

Medtronic's next scheduled report is on Nov 17, 2026. Analysts expect EPS of $1.33.

What is the MDT price target?

The median analyst price target from 26 analysts is $106.00, with a range of $85.00 – $121.00.

Is MDT Shariah compliant?

Nama's AAOIFI-style screen reads Medtronic as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Does MDT pay a dividend?

Yes — Medtronic's dividend yield is 2.8%.

Nama Insights

Medtronic (MDT)

Healthcare · Medical Devices · NYSE

S&P 500

Medtronic (MDT) is a Healthcare company in the Medical Devices industry. It has a market capitalization of $130.22B, a trailing price-to-earnings ratio of 17.8 and a free-cash-flow yield of 4.1%. Over the most recent reported fiscal year, revenue grew 8.4% and free cash flow per share grew 4.8%. Nama's AI scorecard rates it Buy, 6.3 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Buy · 6.3/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Lagging · -5.0% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-17.9%

How far the last close sits under the highest price of the past five years.

Market cap	$130.22B
Trailing P/E	17.8
Price / book	2.6
Price / sales	3.5
FCF yield	4.1%
Dividend yield	2.8%
Gross margin	65.0%
Operating margin	19.0%
Net margin	13.9%
Revenue growth (YoY)	+8.4%
Revenue growth (3-yr annual)	+5.2%
EPS growth (YoY)	+0.6%
FCF/share growth (YoY)	+4.8%
Beta	0.6
Exchange	NYSE
Sector	Healthcare
Industry	Medical Devices

MDT earnings

Next report: Nov 17, 2026 (Q2 2027, EPS estimate $1.33). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q1 2027	Sep 1, 2026	$1.45	$1.39	+4.3%	$9.76B
Q4 2026	Jun 3, 2026	$1.55	$1.54	+0.7%	$9.81B
Q3 2026	Feb 17, 2026	$1.36	$1.34	+1.5%	$9.02B
Q2 2026	Nov 18, 2025	$1.36	$1.31	+3.8%	$8.96B

MDT analyst price target

Median target $106.00 from 26 analysts, ranging $85.00 – $121.00.

Medical Devices peers

Ticker	Company	Market cap	P/E
ABT	Abbott Laboratories	$190.39B	20.4
SYK	Stryker	$124.06B	22.8
BSX	Boston Scientific	$61.96B	13.4
EW	Edwards Lifesciences	$58.73B	34.7
GEHC	GE HealthCare Technologies	$37.25B	16.8
PHG	Koninklijke Philips	$29.67B	15.2
DXCM	DexCom	$29.62B	29.7
STE	STERIS	$24.60B	23.2

Explore live MDT data on Nama Insights →

Recent Congressional trades

Medtronic trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Kevin Hern	House	Sell	$15,001 - $50,000	Sep 1, 2026
Richard Dean McCormick	House	Sell	$1,001 - $15,000	Aug 14, 2026
Julie Johnson	House	Sell	$1,001 - $15,000	Aug 5, 2026
Thomas H Tuberville	Senate	Sell	$15,001 - $50,000	Aug 5, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Gilbert Cisneros	House	Sell	$1,001 - $15,000	Jun 8, 2026
Kevin Hern	House	Sell	$15,001 - $50,000	Apr 3, 2026
Julie Johnson	House	Sell	$1,001 - $15,000	Jan 15, 2026
Julie Johnson	House	Sell	$1,001 - $15,000	Dec 11, 2025
Richard Dean McCormick	House	Buy	$1,001 - $15,000	Dec 9, 2025
Richard Dean McCormick	House	Buy	$1,001 - $15,000	Sep 17, 2025
Julie Johnson	House	Sell	$1,001 - $15,000	Sep 11, 2025

MDT FAQ

Is MDT a buy?: Nama's AI scorecard currently rates Medtronic Buy (6.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is MDT's P/E ratio?: Medtronic trades at a trailing price-to-earnings ratio of 17.8.
When does MDT report earnings?: Medtronic's next scheduled report is on Nov 17, 2026. Analysts expect EPS of $1.33.
What is the MDT price target?: The median analyst price target from 26 analysts is $106.00, with a range of $85.00 – $121.00.
Is MDT Shariah compliant?: Nama's AAOIFI-style screen reads Medtronic as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does MDT pay a dividend?: Yes — Medtronic's dividend yield is 2.8%.